To include your compound in the COVID-19 Resource Center, submit it here.

Cancer

INDICATION: Melanoma

Cell culture studies suggest inhibiting PRKCD, PKCE or RASGRP3 could help treat GNAQ-mutant uveal melanoma. Levels

Read the full 172 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE